Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
29.50
+5.22 (21.50%)
Oct 29, 2025, 10:55 AM EDT - Market open

Beta Bionics Statistics

Total Valuation

Beta Bionics has a market cap or net worth of $1.28 billion. The enterprise value is $834.45 million.

Market Cap1.28B
Enterprise Value 834.45M

Important Dates

The last earnings date was Tuesday, October 28, 2025, after market close.

Earnings Date Oct 28, 2025
Ex-Dividend Date n/a

Share Statistics

Beta Bionics has 43.47 million shares outstanding. The number of shares has increased by 401.79% in one year.

Current Share Class 44.02M
Shares Outstanding 43.47M
Shares Change (YoY) +401.79%
Shares Change (QoQ) +0.56%
Owned by Insiders (%) 3.67%
Owned by Institutions (%) 75.77%
Float 23.70M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.54
Forward PS 9.72
PB Ratio 3.62
P/TBV Ratio 3.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 9.42
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.64, with a Debt / Equity ratio of 0.03.

Current Ratio 10.64
Quick Ratio 9.46
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -47.52% and return on invested capital (ROIC) is -25.03%.

Return on Equity (ROE) -47.52%
Return on Assets (ROA) -20.08%
Return on Invested Capital (ROIC) -25.03%
Return on Capital Employed (ROCE) -22.52%
Revenue Per Employee $301,259
Profits Per Employee -$264,769
Employee Count294
Asset Turnover 0.41
Inventory Turnover 2.54

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 21.44
200-Day Moving Average n/a
Relative Strength Index (RSI) 75.84
Average Volume (20 Days) 594,395

Short Selling Information

The latest short interest is 4.17 million, so 9.59% of the outstanding shares have been sold short.

Short Interest 4.17M
Short Previous Month 6.38M
Short % of Shares Out 9.59%
Short % of Float 17.59%
Short Ratio (days to cover) 0.05

Income Statement

In the last 12 months, Beta Bionics had revenue of $88.57 million and -$77.84 million in losses. Loss per share was -$2.50.

Revenue88.57M
Gross Profit 48.28M
Operating Income -68.59M
Pretax Income -77.84M
Net Income -77.84M
EBITDA -67.33M
EBIT -68.59M
Loss Per Share -$2.50
Full Income Statement

Balance Sheet

The company has $228.69 million in cash and $7.69 million in debt, giving a net cash position of $221.00 million or $5.08 per share.

Cash & Cash Equivalents 228.69M
Total Debt 7.69M
Net Cash 221.00M
Net Cash Per Share $5.08
Equity (Book Value) 294.76M
Book Value Per Share 6.70
Working Capital 244.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.58 million and capital expenditures -$3.96 million, giving a free cash flow of -$60.53 million.

Operating Cash Flow -56.58M
Capital Expenditures -3.96M
Free Cash Flow -60.53M
FCF Per Share -$1.39
Full Cash Flow Statement

Margins

Gross margin is 54.51%, with operating and profit margins of -77.45% and -87.89%.

Gross Margin 54.51%
Operating Margin -77.45%
Pretax Margin -87.89%
Profit Margin -87.89%
EBITDA Margin -76.02%
EBIT Margin -77.45%
FCF Margin n/a

Dividends & Yields

Beta Bionics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -401.79%
Shareholder Yield -401.79%
Earnings Yield -7.38%
FCF Yield -5.74%

Analyst Forecast

The average price target for Beta Bionics is $26.64, which is -9.69% lower than the current price. The consensus rating is "Strong Buy".

Price Target $26.64
Price Target Difference -9.69%
Analyst Consensus Strong Buy
Analyst Count 11
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2